MENU
ABCL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
AbCellera Biologics (ABCL) Ownership - Who owns AbCellera Biologics?
AbCellera Biologics Inc is an antibody discovery and development engine that’s specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner... Show more
Profile
Industry
N/A
Address
2215 Yukon Street
Phone
+1 604 559-9005
Employees
586
Web
https://www.abcellera.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
661.53M
P/E Ratio
N/A
Total Cash
625.61M
Projected Growth
N/A
Total Debt
65.36M
Revenue
28.83M
Risk (Beta)
0.89
Dividend Yield
N/A
Total Cash/Share
2.10
Total Debt/Equity
N/A
Revenue/Share
0.10 USD as % of share price
Fundamentals
ABCL
Capitalization
662M
P/E Ratio
N/A
Risk (Beta)
0.89
Dividend Yield
N/A
Total Cash
626M
Total Cash/Share
2.10
Total Debt
65.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.10%
Revenue
28.8M
ROE
N/A
Book Value
1.06B
P/B Ratio
0.63
Cash Flow
N/A
Earnings
-0.55
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
777M
Current Ratio
9.81
Current Revenue Per Employee
8473.15
Dividends Per Share - Security
N/A
EBITDA
-204.15M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-11.43
Shares Held By Institutions
2.57B
Shares Outstanding - Current
298M
Total Liabilities
304M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-24.232
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2215 Yukon Street
Phone
+1 604 559-9005
Employees
586
Web
https://www.abcellera.com